Studies have shown that ERS becomes prominent upon reperfusion but not during ischemia, while inhibition of ERS could protect the heart from ischemia reperfusion injury by modulation of the mPTP opening through inactivation of GSK-3β in vivo and in vitro [17, 18]. Here, GSK3B is linked to ischemia.